Urine bikunin as a marker of renal impairment in Fabry's disease

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Lepedda, Antonio Junior ^a   Fancellu, Laura ^a   Zinellu, Elisabetta ^a   De Muro, Pierina ^a   Nieddu, Gabriele ^a   Deiana, Giovanni Andrea ^a   Canu, Piera ^a   Concolino, Daniela ^b   Sestito, Simona ^b   Formato, Marilena ^a   Sechi, Gianpietro ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b PUGLIESE CIACCIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE; CHONDROITIN SULFATE; CREATININE; ULINASTATIN; ALPHA 1 MICROGLOBULIN; ALPHA GLOBULIN; ALPHA-1-MICROGLOBULIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; ENZYME ACTIVITY; ENZYME REPLACEMENT; ERYTHROCYTE SEDIMENTATION RATE; FABRY DISEASE; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN URINE LEVEL; PROTEINURIA; URINALYSIS; URINARY EXCRETION; GENETICS; KIDNEY; METABOLISM; MIDDLE AGED; PATHOLOGY; URINE; COMPLICATION;

ADULT; ALPHA-GALACTOSIDASE; ALPHA-GLOBULINS; BIOLOGICAL MARKERS; FABRY DISEASE; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; PROTEINURIA; RENAL INSUFFICIENCY;

EID: 84880149177     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/205948     Document Type: Article

References (34)

1. Zarate Y. A., Hopkin R. J., Fabry's disease. The Lancet 2008 372 9647 1427 1435 2-s2.0-53749104902 10.1016/S0140-6736(08)61589-5
2. Desnick R. J., Brady R. O., Fabry disease in childhood. Journal of Pediatrics 2004 144 5, Supplement S20 S26 2-s2.0-2342524106 10.1016/j.jpeds. 2004.01.051
3. Breunig F., Wanner C., Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy. Journal of Nephrology 2008 21 1 32 37 2-s2.0-43249124728
4. Schiffmann R., Fabry disease. Pharmacology and Therapeutics 2009 122 1 65 77 2-s2.0-63149135596 10.1016/j.pharmthera.2009.01.003
5. Torralba-Cabeza M., Olivera S., Hughes D. A., Pastores G. M., Mateo R. N., Pérez-Calvo J., Cystatin C and NT-proBNP as prognostic biomarkers in Fabry disease. Molecular Genetics and Metabolism 2011 104 3 301 307 2-s2.0-82455164334 10.1016/j.ymgme.2011.06.021
6. Esko J. D., Kimata K., Lindahl U., Varki A., Cummings R. D., Esko J. D., Proteoglycans and sulfated glycosaminoglycans. Essential of Glycobiology 2009 2nd Chapter 16 Cold Spring Harbor, NY, USA Cold Spring Harbor Laboratory Press
7. Ly M., Leach F. E., Laremore T. N., Toida T., Amster I. J., Linhardt R. J., The proteoglycan bikunin has a defined sequence. Nature Chemical Biology 2011 7 11 827 833 2-s2.0-80054871765 10.1038/nchembio.673
8. Zinellu A., Pisanu S., Zinellu E., Lepedda A. J., Cherhi G. M., Sotgia S., Carru C., Deiana L., Formato M., A novel LIF-CE method for the separation of hyalurnan- and chondroitin sulfate-derived disaccharides: application to structural and quantitative analyses of human plasma low- and high-charged chondroitin sulfate isomers. Electrophoresis 2007 28 14 2439 2447 2-s2.0-34547462502 10.1002/elps.200600668
9. Zinellu E., Lepedda A. J., Cigliano A., Pisanu S., Zinellu A., Carru C., Bacciu P. P., Piredda F., Guarino A., Spirito R., Formato M., Association between human plasma chondroitin sulfate isomers and carotid atherosclerotic plaques. Biochemistry Research International 2012 2012 6 2-s2.0-84855712716 10.1155/2012/281284 281284
10. Zhuo L., Hascall V. C., Kimata K., Inter- α -trypsin inhibitor, a covalent protein-glycosaminoglycan- protein complex. Journal of Biological Chemistry 2004 279 37 38079 38082 2-s2.0-4644353637 10.1074/jbc.R300039200
11. Matsuzaki H., Kobayashi H., Yagyu T., Wakahara K., Kondo T., Kurita N., Sekino H., Inagaki K., Suzuki M., Kanayama N., Terao T., Plasma bikunin as a favorable prognostic factor in ovarian cancer. Journal of Clinical Oncology 2005 23 7 1463 1472 2-s2.0-20144382991 10.1200/JCO.2005.03.010
12. De Muro P., Faedda R., Satta A., Finetti D., Masala A., Cigni A., Sanna G. M., Cherchi G. M., Urinary glycosaminoglycan composition in chronic glomerulonephritis. Journal of Nephrology 2005 18 2 154 160 2-s2.0-20744432341
13. De Muro P., Faedda R., Satta A. E., Masala A., Cigni A., Falconi D., Sanna G. M., Cherchi G. M., Quali-quantitative analysis of urinary glycosaminoglycans for monitoring glomerular inflammatory activity. Scandinavian Journal of Urology and Nephrology 2007 41 3 230 236 2-s2.0-34247634078 10.1080/00365590601017105
14. De Muro P., Faedda R., Masala A., Lepedda A. J., Zinellu E., Ciccarese M., Cossu M., Pala P. G., Satta R. P., Formato M., Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN- γ (MIG). Clinical and Experimental Medicine 2013 13 1 59 65 2-s2.0-84857004143 10.1007/s10238-012-0178-5
15. De Muro P., Fresu P., Tonolo G., Maioli M., Cherchi G. B., Murgia A., Ibba C., Sanna G. M., Cherchi G. M., A longitudinal evaluation of urinary glycosaminoglycan excretion in normoalbuminuric type 1 diabetic patients. Clinical Chemistry and Laboratory Medicine 2006 44 5 561 567 2-s2.0-33646677485 10.1515/CCLM.2006.097
16. De Muro P., Faedda R., Formato M., Re F., Satta A., Cherchi G. M., Carcassi A., Urinary glycosaminoglycans in patients with systemic lupus erythematosus. Clinical and Experimental Rheumatology 2001 19 2 125 130 2-s2.0-0035039839
17. De Muro P., Capobianco G., Formato M., Lepedda A. J., Cherchi G. M., Gordini L., Dessole S., Glycosaminoglycan and transforming growth factor β 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. Fertility and Sterility 2009 92 1 320 327 2-s2.0-67649095478 10.1016/j.fertnstert.2008.05.066
18. Pugia M. J., Valdes R. Jr., Jortani S. A., Bikunin (urinary trypsin inhibitor): structure, biological relevance, and measurement. Advances in Clinical Chemistry 2007 44 223 245 2-s2.0-34347204795 10.1016/S0065-2423(07) 44007-0
19. De Lin S., Endo R., Kuroda H., Kondo K., Miura Y., Takikawa Y., Kato A., Suzuki K., Plasma and urine levels of urinary trypsira inhibitor in patients with chronic liver diseases and hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2004 19 3 327 332 2-s2.0-1542721855 10.1111/j.1440-1746.2003.03221.x
20. Sakai K., Okudera H., Hongo K., Significant elevation of urinary trypsin inhibitor in patients with brain contusion-a preliminary report. Journal of Clinical Neuroscience 2003 10 6 677 679 2-s2.0-0242558027 10.1016/S0967-5868(03) 00073-0
21. Bitter T., Muir H. M., A modified uronic acid carbazole reaction. Analytical Biochemistry 1962 4 4 330 334 2-s2.0-50549161624
22. Cappelletti R., Del Rosso M., Chiarugi V. P., A new electrophoretic method for the complete separation of all known animal glycosaminoglycans in a monodimensional run. Analytical Biochemistry 1979 99 2 311 315 2-s2.0-0018635975
23. Zinellu A., Lepedda A. Jr., Sotgia S., Zinellu E., Marongiu G., Usai M. F., Gaspa L., De Muro P., Formato M., Deiana L., Carru C., Albumin-bound low molecular weight thiols analysis in plasma and carotid plaques by CE. Journal of Separation Science 2010 33 1 126 131 2-s2.0-75349094905 10.1002/jssc.200900582
24. Branton M. H., Schiffmann R., Sabnis S. G., Murray G. J., Quirk J. M., Altarescu G., Goldfarb L., Brady R. O., Balow J. E., Austin H. A. III, Kopp J. B., Natural history of fabry renal disease: influence of α -galactosidase a activity and genetic mutations on clinical course. Medicine 2002 81 2 122 138 2-s2.0-0036122659 10.1097/00005792-200203000-00003
25. Mehta A., Beck M., Elliott P., Giugliani R., Linhart A., Sunder-Plassmann G., Schiffmann R., Barbey F., Ries M., Clarke J., Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data. The Lancet 2009 374 9706 1986 1996 2-s2.0-71649111830 10.1016/S0140- 6736(09)61493-8
26. Warnock D. G., West M. L., Diagnosis and management of kidney involvement in fabry disease. Advances in Chronic Kidney Disease 2006 13 2 138 147 2-s2.0-33645454578 10.1053/j.ackd.2006.01.013
27. Ries M., Clarke J. T. R., Whybra C., Timmons M., Robinson C., Schlaggar B. L., Pastores G., Lien Y. H., Kampmann C., Brady R. O., Beck M., Schiffmann R., Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease. Pediatrics 2006 118 3 924 932 2-s2.0-33749067655 10.1542/peds.2005-2895
28. Schiffmann R., Waldek S., Benigni A., Auray-Blais C., Biomarkers of fabry disease nephropathy. Clinical Journal of the American Society of Nephrology 2010 5 2 360 364 2-s2.0-77749325059 10.2215/CJN.06090809
29. Ortu E., Fancellu L., Sau G., Falchi P., Traccis S., Pes G. M., Ganau A., Sechi G., Primary motor cortex hyperexcitability in Fabry's disease. Clinical Neurophysiology 2013 10.1016/j.clinph.2013.02.005
30. Vedder A. C., Biró É., Aerts J. M. F. G., Nieuwland R., Sturk G., Hollak C. E. M., Plasma markers of coagulation and endothelial activation in Fabry disease: impact of renal impairment. Nephrology Dialysis Transplantation 2009 24 10 3074 3081 2-s2.0-70349503926 10.1093/ndt/gfp263
31. Kikumoto Y., Kai Y., Morinaga H., Iga-Murahashi M., Matsuyama M., Sasaki T., Maruyama H., Shimotori M., Makino H., Sugiyama H., Okayama A., Fabry disease exhibiting recurrent stroke and persistent inflammation. Internal Medicine 2010 49 20 2247 2252 2-s2.0-78449306112 10.2169/internalmedicine.49.3724
32. Futerman A. H., Van Meer G., The cell biology of lysosomal storage disorders. Nature Reviews Molecular Cell Biology 2004 5 7 554 565 2-s2.0-2942687937 10.1038/nrm1423
33. Vitner E. B., Platt F. M., Futerman A. H., Common and uncommon pathogenic cascades in lysosomal storage diseases. Journal of Biological Chemistry 2010 285 27 20423 20427 2-s2.0-77954225471 10.1074/jbc.R110.134452
34. Itoh H., Tomita M., Kobayashi T., Uchino H., Maruyama H., Nawa Y., Expression of inter- α -trypsin inhibitor light chain (bikunin) in human pancreas. Journal of Biochemistry 1996 120 2 271 275 2-s2.0-0029682092.